ANIX — Anixa Biosciences Share News
0.000.00%
Last trade - 00:00US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: Anixa Biosciences Reports Updated Positive Survival Observations From Ongoing Phase 1 Trial Of Lira-Cel Ovarian Cancer CAR-T Therapy
Brief: Anixa Biosciences Announces Issuance Of Mexican Patent Covering Breast Cancer Vaccine Technology
U.S. STOCKS ON THE MOVE-Eli Lilly, Space stocks, Anixa Biosciences
Brief: Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results Cytovance Selected For Cgmp Manufacturing
Anixa rises after lining up update on ovarian cancer therapy trial
Brief: Anixa Biosciences Announces Presentation Of Its Ovarian Cancer Car-T Therapy Clinical Trial
Brief: Anixa Biosciences To Host 2026 Annual Meeting Of Stockholders And Provide Corporate Update Highlighting Recent Clinical And Regulatory Progress
Brief: Anixa Biosciences Reports Encouraging Patient Survival Observations In Ovarian Cancer Car-T Trial
Anixa Biosciences rises after Mexico approves patent for breast cancer vaccine
Brief: Cleveland Clinic Transfers Breast Cancer Vaccine IND to Anixa
NASDAQ RESUMED AT 09:46 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:41 AM
Brief: Anixa Biosciences Announces World Health Organization (Who) Approval Of International Non-Proprietary Name For Its Car-T Therapy, Marking A Key Milestone Toward Global Recognition And Future Commercialization
Brief: Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
Brief: Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology